N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141223 |
| CAS No | NA |
| Mol.F. | C25H29F3N4O4 |
| Mol.Wt. | 506.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141224 |
| CAS No | NA |
| Mol.F. | C32H33F3N4O5 |
| Mol.Wt. | 610.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141225 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141226 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141227 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141228 |
| CAS No | NA |
| Mol.F. | C13H21N5O2S |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141229 |
| CAS No | NA |
| Mol.F. | C20H30N8O2S2 |
| Mol.Wt. | 478.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141230 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141231 |
| CAS No | NA |
| Mol.F. | C10H16N4OS |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141232 |
| CAS No | NA |
| Mol.F. | C17H13N5O3 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141233 |
| CAS No | NA |
| Mol.F. | C9H9N3O2 |
| Mol.Wt. | 191.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141234 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141235 |
| CAS No | NA |
| Mol.F. | C26H23N5O5 |
| Mol.Wt. | 485.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141236 |
| CAS No | NA |
| Mol.F. | C27H19F3N8O2 : HCl |
| Mol.Wt. | 544.5 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141237 |
| CAS No | NA |
| Mol.F. | C19H17N5O3 |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141238 |
| CAS No | NA |
| Mol.F. | C27H25N5O5 |
| Mol.Wt. | 499.5 |
| INV STATUS | CUSTOM SYNTHESIS |